Affitech appoints Dr Keith McCullagh chairman
This article was originally published in Scrip
The Norwegian antibody therapeutics company Affitech has appointed Dr Keith McCullagh non-executive chairman of its board of directors. The company's previous chairman, Oyvin Broymer, will remain as a member of the board. Dr McCullagh was most recently CEO at Santaris Pharma in Denmark.